110 related articles for article (PubMed ID: 8501998)
1. Adherence to continuous screening for colorectal neoplasia.
Myers RE; Balshem AM; Wolf TA; Ross EA; Millner L
Med Care; 1993 Jun; 31(6):508-19. PubMed ID: 8501998
[TBL] [Abstract][Full Text] [Related]
2. Analysis of colorectal cancer stage among HMO members targeted for screening.
Myers RE; Murray J; Weinberg D; McGrory G; Wolf T; Caveny J; Hanchak N; Schlackman N; Comis R
Arch Intern Med; 1997 Sep; 157(17):2001-6. PubMed ID: 9308512
[TBL] [Abstract][Full Text] [Related]
3. Behavioral interventions to increase adherence in colorectal cancer screening.
Myers RE; Ross EA; Wolf TA; Balshem A; Jepson C; Millner L
Med Care; 1991 Oct; 29(10):1039-50. PubMed ID: 1921523
[TBL] [Abstract][Full Text] [Related]
4. A Systematic Review of Repeat Fecal Occult Blood Tests for Colorectal Cancer Screening.
Murphy CC; Sen A; Watson B; Gupta S; Mayo H; Singal AG
Cancer Epidemiol Biomarkers Prev; 2020 Feb; 29(2):278-287. PubMed ID: 31740521
[TBL] [Abstract][Full Text] [Related]
5. A case-control study to evaluate efficacy of screening for faecal occult blood.
Lazovich D; Weiss NS; Stevens NG; White E; McKnight B; Wagner EH
J Med Screen; 1995; 2(2):84-9. PubMed ID: 7497161
[TBL] [Abstract][Full Text] [Related]
6. Adherence to colorectal cancer screening in an HMO population.
Myers RE; Trock BJ; Lerman C; Wolf T; Ross E; Engstrom PF
Prev Med; 1990 Sep; 19(5):502-14. PubMed ID: 2235919
[TBL] [Abstract][Full Text] [Related]
7. Lower risk of advanced neoplasia among patients with a previous negative result from a fecal test for colorectal cancer.
Denters MJ; Deutekom M; Bossuyt PM; Stroobants AK; Fockens P; Dekker E
Gastroenterology; 2012 Mar; 142(3):497-504. PubMed ID: 22108194
[TBL] [Abstract][Full Text] [Related]
8. A randomized trial of direct mailing of fecal occult blood tests to increase colorectal cancer screening.
Church TR; Yeazel MW; Jones RM; Kochevar LK; Watt GD; Mongin SJ; Cordes JE; Engelhard D
J Natl Cancer Inst; 2004 May; 96(10):770-80. PubMed ID: 15150305
[TBL] [Abstract][Full Text] [Related]
9. Impact of continued mailed fecal tests in the patient-centered medical home: Year 3 of the Systems of Support to Increase Colon Cancer Screening and Follow-Up randomized trial.
Green BB; Anderson ML; Chubak J; Fuller S; Meenan RT; Vernon SW
Cancer; 2016 Jan; 122(2):312-21. PubMed ID: 26488332
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal adherence with fecal occult blood test screening in community practice.
Fenton JJ; Elmore JG; Buist DS; Reid RJ; Tancredi DJ; Baldwin LM
Ann Fam Med; 2010; 8(5):397-401. PubMed ID: 20843880
[TBL] [Abstract][Full Text] [Related]
11. Participation in colorectal cancer screening: a review.
Vernon SW
J Natl Cancer Inst; 1997 Oct; 89(19):1406-22. PubMed ID: 9326910
[TBL] [Abstract][Full Text] [Related]
12. Colorectal cancer screening adherence is higher with fecal immunochemical tests than guaiac-based fecal occult blood tests: a randomized, controlled trial.
Hoffman RM; Steel S; Yee EF; Massie L; Schrader RM; Murata GH
Prev Med; 2010; 50(5-6):297-9. PubMed ID: 20307568
[TBL] [Abstract][Full Text] [Related]
13. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates.
Segnan N; Senore C; Andreoni B; Arrigoni A; Bisanti L; Cardelli A; Castiglione G; Crosta C; DiPlacido R; Ferrari A; Ferraris R; Ferrero F; Fracchia M; Gasperoni S; Malfitana G; Recchia S; Risio M; Rizzetto M; Saracco G; Spandre M; Turco D; Turco P; Zappa M;
J Natl Cancer Inst; 2005 Mar; 97(5):347-57. PubMed ID: 15741571
[TBL] [Abstract][Full Text] [Related]
14. Modeling adherence to colorectal cancer screening.
Myers RE; Ross E; Jepson C; Wolf T; Balshem A; Millner L; Leventhal H
Prev Med; 1994 Mar; 23(2):142-51. PubMed ID: 8047519
[TBL] [Abstract][Full Text] [Related]
15. From the bench to public health: population-level implementation intentions in colorectal cancer screening.
Neter E; Stein N; Barnett-Griness O; Rennert G; Hagoel L
Am J Prev Med; 2014 Mar; 46(3):273-80. PubMed ID: 24512866
[TBL] [Abstract][Full Text] [Related]
16. Screening with faecal occult blood test (FOBT) for colorectal cancer: assessment of two methods that attempt to improve compliance.
Ore L; Hagoel L; Lavi I; Rennert G
Eur J Cancer Prev; 2001 Jun; 10(3):251-6. PubMed ID: 11432712
[TBL] [Abstract][Full Text] [Related]
17. Colorectal cancer screening in LHU4 Chiavarese, Italy: ethical, methodological and outcome evaluations at the end of the first round.
Ferrari Bravo M; De Conca V; Devoto GL; Sironi M; Mele R; Fumagalli A; Rimassa P; Rossi G; Zampogna A; Sticchi C; Gabutti G;
J Prev Med Hyg; 2012 Mar; 53(1):37-43. PubMed ID: 22803318
[TBL] [Abstract][Full Text] [Related]
18. A national survey of primary care physicians' methods for screening for fecal occult blood.
Nadel MR; Shapiro JA; Klabunde CN; Seeff LC; Uhler R; Smith RA; Ransohoff DF
Ann Intern Med; 2005 Jan; 142(2):86-94. PubMed ID: 15657156
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with adherence to fecal occult blood testing for colorectal cancer screening among adults in the Republic of Korea.
Bae N; Park S; Lim S
Eur J Oncol Nurs; 2014 Feb; 18(1):72-7. PubMed ID: 24183583
[TBL] [Abstract][Full Text] [Related]
20. Effect of Colonoscopy Outreach vs Fecal Immunochemical Test Outreach on Colorectal Cancer Screening Completion: A Randomized Clinical Trial.
Singal AG; Gupta S; Skinner CS; Ahn C; Santini NO; Agrawal D; Mayorga CA; Murphy C; Tiro JA; McCallister K; Sanders JM; Bishop WP; Loewen AC; Halm EA
JAMA; 2017 Sep; 318(9):806-815. PubMed ID: 28873161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
